Bond Labs' NDS Nutrition to Attend FILEX Convention in Australia


Bond Laboratories, Inc. (OTCBB:BNLB) (Bond Labs), an international provider of innovative and proprietary nutritional supplements for health conscious consumers, marketed primarily through its wholly owned operating division, NDS Nutrition Products (NDS), announces that the Company will attend and participate in the FILEX 2013 Fitness Industry Convention, held in conjunction with the Australian Fitness & Health Expo, April 19-21, at the Sydney Convention & Exhibition Centre in Sydney, Australia.

The FILEX 2013 Convention is an exceptional opportunity for NDS to increase its brand awareness and maximize the Companys visibility in Australias expanding health and fitness market, stated John Wilson, Bond Labs CEO. The Convention brings together health and fitness professionals and healthy lifestyle enthusiasts from across Australia. Our presence at FILEX further reinforces NDS as an established provider of premium nutritional supplements to the Australian market and represents an exciting forum to showcase several new products as we continue to expand our footprint in market.

We initially entered the Australian market during the third quarter of 2012. Since that time, we have steadily increased the number of NDS products sold at GNC franchise locations, continued Mr. Wilson. We are very pleased with the strong consumer response we have received thus far and will continue to work to further our brand recognition and our sales.

About Bond Labs

Bond Laboratories is a manufacturer of innovative nutritional supplements. The Company produces and markets products through its NDS Nutrition division. NDS products number over 50 brands of energy, sports and dietary supplements. These products are sold directly through specialty health and nutrition retailers, including top-selling products at GNC franchises. Bond Labs is headquartered in Omaha, Nebraska. For more information, please visit

Forward-Looking Statement

Statements in this release that are forward looking involve known and unknown risks and uncertainties, which may cause the Companys actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to: the ability to of the Company to continue to grow revenue; the Companys ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs; and the outcome of the Companys pending litigation with the U.S. Department of Labor and our former President alleging violations of certain unlawful employment practices in connection with his separation from the Company. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in The Companys filings with the Securities and Exchange Commission, including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

Visit link:
Bond Labs' NDS Nutrition to Attend FILEX Convention in Australia

Related Post

Comments are closed.